| 704258 |
FRONTIERS IN ONCOLOGY |
The Neurogenic Compound P7C3 Regulates the Aerobic Glycolysis by Targeting Phosphoglycerate Kinase 1 in Glioma |
2021-06-18 |
10.3389/fonc.2021.644492 |
Chen Wenjin, Jia Weiqiang, Wu Cuiying, Chen Lihua, Sun Kai, Wang Ji, Ding Boyun, Liu Ning, Xu Ruxiang |
| 704257 |
FRONTIERS IN ONCOLOGY |
A Novel Classification of Glioma Subgroup, Which Is Highly Correlated With the Clinical Characteristics and Tumor Tissue Characteristics, Based on the Expression Levels of Gβ and Gγ Genes |
2021-06-18 |
10.3389/fonc.2021.685823 |
Cai Zehao, Yu Chunna, Li Shenglan, Wang Can, Fan Yaqiong, Ji Qiang, Chen Feng, Li Wenbin |
| 704256 |
FRONTIERS IN ONCOLOGY |
LncRNA FGD5-AS1 Facilitates the Radioresistance of Breast Cancer Cells by Enhancing MACC1 Expression Through Competitively Sponging miR-497-5p |
2021-06-18 |
10.3389/fonc.2021.671853 |
Li Ji, Lei Changjiang, Chen Bineng, Zhu Qingfang |
| 704255 |
FRONTIERS IN ONCOLOGY |
The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer |
2021-06-18 |
10.3389/fonc.2021.619949 |
Zhang Xixun |
| 704254 |
FRONTIERS IN ONCOLOGY |
A Fibrinogen Alpha Fragment Mitigates Chemotherapy-Induced MLL Rearrangements |
2021-06-18 |
10.3389/fonc.2021.689063 |
Eberle Julia, Wiehe Rahel Stefanie, Gole Boris, Mattis Liska Jule, Palmer Anja, Ständker Ludger, Forssmann Wolf-Georg, Münch Jan, Gebhardt J. Christof M., Wiesmüller Lisa |
| 704253 |
FRONTIERS IN ONCOLOGY |
Cohort Profile: Chinese Cervical Cancer Clinical Study |
2021-06-18 |
10.3389/fonc.2021.690275 |
Zhang Xi-Ru, Li Zhi-Qiang, Sun Li-Xin, Liu Ping, Li Zhi-Hao, Li Peng-Fei, Zhao Hong-Wei, Chen Bi-Liang, Ji Mei, Wang Li, Kang Shan, Lang Jing-He, Mao Chen, Chen Chun-Lin |
| 704252 |
FRONTIERS IN ONCOLOGY |
Association of Mu-Opioid Receptor(MOR) Expression and Opioids Requirement With Survival in Patients With Stage I-III Pancreatic Ductal Adenocarcinoma |
2021-06-18 |
10.3389/fonc.2021.686877 |
Zhang Hao, Qu Mengdi, Gorur Aysegul, Sun Zhirong, Cata Juan P., Chen Wankun, Miao Changhong |
| 704251 |
FRONTIERS IN ONCOLOGY |
A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case Report |
2021-06-18 |
10.3389/fonc.2021.671416 |
Wang Jianzheng, Li Qingli, Lv Huifang, Nie Caiyun, Chen Beibei, Xu Weifeng, Yang Tiejun, Zhang Yinping, Tu Shuiping, Chen Xiaobing |
| 704250 |
FRONTIERS IN ONCOLOGY |
Tetraspanins: Novel Molecular Regulators of Gastric Cancer |
2021-06-18 |
10.3389/fonc.2021.702510 |
Deng Yue, Cai Sicheng, Shen Jian, Peng Huiming |
| 704249 |
FRONTIERS IN ONCOLOGY |
Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling |
2021-06-18 |
10.3389/fonc.2021.698888 |
Tan Yufan, Zhong Xiaoyu, Wen Xizhi, Yao Leyi, Shao Zhenlong, Sun Wenshuang, Wu Jiawen, Wen Guanmei, Tang Daolin, Zhang Xiaoshi, Liao Yuning, Liu Jinbao |
